ENTITY
Mayne Pharma

Mayne Pharma (MYX AU)

224
Analysis
Health Care • Australia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
bearish•Macroeconomics
•01 Apr 2015 11:31

Taxing Times For Australia

The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...

Logo
6.1k Views
Share
•09 Mar 2026 05:30

S&P/​​​​ASX Index Rebalance (Mar 2026): 43 Changes Across Indices as Adds Outperform Deletes

There are 43 changes across the ASX changes in March. Couple of the adds could also be added to the GDX in March. The adds have outperformed the...

Logo
837 Views
Share
bullish•Regis Resources
•27 Feb 2026 05:57

S&P/​​​​​​​​​ASX Index Rebalance Preview (Mar 26): Plenty of Change with Big Flow & Impact

There could be 46 changes across the ASX family of indices in March. Passive trackers need to trade a lot of stock in many names. Some names are...

Logo
1k Views
Share
bullish•Lynas Corp Ltd
•02 Feb 2026 06:15

Aussie Shorts (23rd Jan 2026): Lynas, Light & Wonder, Domino's Pizza, Amcor, Boss Energy

Companies mentioned in this (soon-to-be-regular) weekly report include Lynas Corp (LYC AU), Light & Wonder (LNW US), Domino's Pizza Enterprises...

Logo
470 Views
Share
bearish•IFBH
•18 Dec 2025 10:07

IFBH IPO Lockup - US$262m Lockup Release but the Stock Has Nosedived

IFBH Ltd raised around US$169m from its Hong Kong IPO in June 2025. The lockup on its cornerstone and pre-IPO investors is set to expire soon.

Logo
554 Views
Share
x